TY  - GEN
AU  - Loren,A W
AU  - Luger,S M
AU  - Stadtmauer,E A
AU  - Tsai,D E
AU  - Schuster,S
AU  - Nasta,S D
AU  - Goldstein,S C
AU  - Perl,A
AU  - Orloff,G
AU  - Oliver,J C
AU  - Green,J
AU  - Emerson,S G
AU  - Porter,D L
TI  - Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation
SN  - 0268-3369
PY  - 2005///0818
KW  - Adult
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Neoplasm
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cyclophosphamide
KW  - Female
KW  - Graft vs Host Disease
KW  - complications
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Lymphoproliferative Disorders
KW  - Male
KW  - Middle Aged
KW  - Mycophenolic Acid
KW  - Transplantation Chimera
KW  - Transplantation Conditioning
KW  - methods
KW  - Vidarabine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.bmt.1704887
ER  -